Pathophysiology of polycystic ovary syndrome: The role of hyperandrogenism

Frontiers of Hormone Research

Volumn 40, Issue , 2013, Pages 22-27

  Catteau Jonard, Sophie ^a   Dewailly, Didier ^a  

^a LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; AROMATASE; FOLLITROPIN; MUELLERIAN INHIBITING FACTOR;

ANDROGEN SYNTHESIS; ANOVULATION; ARTICLE; ENVIRONMENTAL FACTOR; EPIGENETICS; FOLLITROPIN BLOOD LEVEL; FOLLITROPIN RELEASE; HUMAN; HYPERANDROGENISM; OVARY FOLLICLE DEVELOPMENT; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; BLOOD; DRUG EFFECTS; FEMALE; METABOLISM; OVARY FOLLICLE; PHYSIOLOGY;

ANTI-MULLERIAN HORMONE; AROMATASE; FEMALE; FOLLICLE STIMULATING HORMONE; HUMANS; HYPERANDROGENISM; OVARIAN FOLLICLE; POLYCYSTIC OVARY SYNDROME;

EID: 84870262452     PISSN: 03013073     EISSN: 16623762     Source Type: Book Series    
DOI: 10.1159/000341679     Document Type: Article

References (26)

1. Norman RJ, Dewailly D, Legro RS, Hickey TE: Polycystic ovary syndrome. Lancet 2007;370:685.
2. Strauss JF III, Dunaif A: Molecular mysteries of polycystic ovary syndrome. Mol Endocrinol 1999; 13:800.
3. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE: Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab 1997;82:2248.
4. Blank SK, McCartney CR, Helm KD, Marshall JC: Neuroendocrine effects of androgens in adult polycystic ovary syndrome and female puberty. Semin Reprod Med 2007;25:352.
5. Baptiste CG, Battista MC, Trottier A, Baillargeon JP: Insulin and hyperandrogenism in women with polycystic ovary syndrome. J Steroid Biochem Mol Biol 2010;122:42.
6. Kelly CJ, Stenton SR, Lashen H: Insulin-like growth factor binding protein-1 in PCOS: a systematic review and meta-analysis. Hum Reprod Update 2011;17:4.
7. Pigny P, Cortet-Rudelli C, Decanter C, Deroubaix D, Soudan B, Duhamel A, Dewailly D: Serum levels of inhibins are differentially altered in patients with PCOS: effects of being overweight and relevance to hyperandrogenism. Fertil Steril 2000;73:972.
8. Wickenheisser JK, Nelson-DeGrave VL, McAllister JM: Human ovarian theca cells in culture. Trends Endocrinol Metab 2006;17:65.
9. Franks S, Berga SL: Does PCOS have developmental origins? Fertil Steril 2012;97:2.
10. Hughesdon PE: Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called hyperthecosis. Obstet Gynecol Surv 1982;37:59.
11. Webber LJ, Stubbs S, Stark J, Trew GH, Margara R, Hardy K, Franks S: Formation and early development of follicles in the polycystic ovary. Lancet 2003;362:1017.
12. Jonard S, Dewailly D: The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest. Hum Reprod Update 2004;10:107.
13. Vendola KA, Zhou J, Adesanya OO, Weil SJ, Bondy CA: Androgens stimulate early stages of follicular growth in the primate ovary. J Clin Invest 1998; 101:2622.
14. Xita N, Tsatsoulis A: Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. J Clin Endocrinol Metab 2006; 91:1660.
15. Jonard S, Robert Y, Cortet-Rudelli C, Pigny P, Decanter C, Dewailly D: Ultrasound examination of polycystic ovaries: is it worth counting the follicles? Hum Reprod 2003;18:598.
16. Fauser BC, Pache TD, Lamberts SW, Hop WC, de Jong F, Dahl KD: Serum bioactive and immunoreactive luteinizing hormone and follicle-stimulating hormone levels in women with cycle abnormalities, with or without polycystic ovarian disease. J Clin Endocrinol Metab 1991;73:811.
17. Franks S, Stark J, Hardy K: Follicle dynamics and anovulation in polycystic ovary syndrome. Hum Reprod Update 2008;14:367.
18. Almahbobi G, Anderiesz C, Hutchinson P, McFarlane JR, Wood C, Trounson AO: Functional integrity of granulosa cells from polycystic ovaries. Clin Endocrinol (Oxf) 1996;44:571.
19. Coffler MS, Patel K, Dahan MH, Malcom PJ, Kawashima T, Deutsch R, Chang RJ: Evidence for abnormal granulosa cell responsiveness to FSH in women with polycystic ovary syndrome. J Clin Endocrinol Metab 2003;88:1742.
20. Dewailly D, Catteau-Jonard S, Reyss AC, Maunoury-Lefebvre C, Poncelet E, Pigny P: The excess in 2-5 mm follicles seen at ovarian ultrasonography is tightly associated to the follicular arrest of the polycystic ovary syndrome. Hum Reprod 2007;22:1562.
21. Weenen C, Laven JS, Von Bergh AR, Cranfield M, Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP: Anti-Mllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77.
22. Pigny P, Jonard S, Robert Y, Dewailly D: Serum anti-Mullerian hormone as a surrogate for antral follicle count for definition of the polycystic ovary syndrome. J Clin Endocrinol Metab 2006;91:941.
23. Dewailly D, Gronier H, Poncelet E, Robin G, Leroy M, Pigny P, Duhamel A, Catteau-Jonard S: Diagnosis of polycystic ovary syndrome (PCOS): revisiting the threshold values of follicle count on ultrasound and of the serum AMH level for the definition of polycystic ovaries. Hum Reprod 2011;26:3123.
24. Pellatt L, Rice S, Mason HD: Anti-Mllerian hormone and polycystic ovary syndrome: a mountain too high? Reproduction 2010;139:825.
25. Franks S, Mason H, White D, Willis D: Etiology of anovulation in polycystic ovary syndrome. Steroids 1998;63:306.
26. Catteau-Jonard S, Pigny P, Reyss AC, Decanter C, Poncelet E, Dewailly D: Changes in serum anti-Mullerian hormone level during low-dose recombinant follicular-stimulating hormone therapy for anovulation in polycystic ovary syndrome. J Clin Endocrinol Metab 2007;92:4138.